J-STAGE Home  >  Publications - Top  > Bibliographic Information

Internal Medicine
Vol. 55 (2016) No. 9 p. 1177-1181

Language:

http://doi.org/10.2169/internalmedicine.55.5223

CASE REPORTS

Philadelphia chromosome positive (Ph+) mixed phenotype acute leukemia (MPAL) is a rare type of acute leukemia having both myeloid and lymphoid features for which no optimal treatment has yet been established. We herein describe two elderly Ph+MPAL patients who achieved molecular remission without any serious adverse events by treatment with dasatinib and prednisolone. Although dasatinib induction therapy combined with prednisolone is known to be a highly effective treatment for Ph+ acute lymphoblastic leukemia, its efficacy for Ph+MPAL has not been shown. The clinical courses of the present cases suggest that combination therapy with dasatinib and prednisolone is a safe and effective therapeutic modality in elderly Ph+MPAL patients.

Copyright © 2016 by The Japanese Society of Internal Medicine

Article Tools

Share this Article